Treatment Outcomes and Associated Factors among Hospitalized Stroke Patients at Shashemene Referral Hospital, Ethiopia
Stroke Research and Treatment · 28.08.2018 · 2018 · 1-5
DOI: 10.1155/2018/8079578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke Research and Treatment, erschienen am 28.08.2018. Verfasst von Tegegne Gobezie Temesgen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Ethiopia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ambo University.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The 2013 Global Burden of Disease report indicated that 80% of stroke deaths occur in low- and middle-income regions. Although stroke has been consistently reported as one of the three leading causes of morbidity and mortality in the past years in Ethiopia, there is a paucity of data regarding treatment outcomes of stroke if sufficient. Hence, the present study aimed to assess patterns of treatment outcomes and associated factors among hospitalized stroke patients at Shashemene Referral Hospital.
Methods
A retrospective cross-sectional study was conducted at the medical ward of Shashemene Referral Hospital. A total of 73 hospitalized stroke patients during the period 2012–2017 were included in the study. Demographic characteristics, risk factors, and stroke types and their hospital outcomes were reviewed from the medical records of the patients. The data were entered and analyzed using SPSS version 16.0. Descriptive statistics such as percent and frequency were used to summarize patients’ characteristics. Binary logistic regression was used to investigate the potential predictors of treatment outcome. A p-value ≤0.05 was considered statistically significant.
Result
Ischemic stroke was the most common type of stroke (65.8%) diagnosed in our setting. Hypertension (52.05%) was the common comorbid condition. More than half (54.79%) of the stroke patients improved on treatment. Dyslipidemics were prescribed to 68.49% of patients and the most popular antiplatelet was aspirin, which was prescribed to 61.64% of the study participants. Age, sex, type of stroke, and type of comorbidity were not significant factors of stroke treatment outcome.
Conclusion
Ischemic stroke was the most common type of stroke diagnosed among the study participants while aspirin and statins were the most frequently used drugs in the management of stroke. Approximately 50% of hospitalized stroke patients had good treatment outcome and none of the investigated variables were significantly associated with the treatment outcomes.
Autor:innen und Institutionen
- Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Ethiopia.
- Ambo University, College of Medicine and Health Sciences, Department of Pharmacy, Ethiopia.
- University of Nairobi, College of Health Sciences, School of Pharmacy, Department of Pharmaceutical Chemistry, Nairobi 19676-00202, Kenya.
ORCID-Profile: Tegegne Gobezie Temesgen
Förderung
- Ambo University
Zitieren
APA
Temesgen, T. G., Teshome, B., & Njogu, P. (2018). Treatment Outcomes and Associated Factors among Hospitalized Stroke Patients at Shashemene Referral Hospital, Ethiopia. Stroke Research and Treatment, 2018, 1-5. https://doi.org/10.1155/2018/8079578
Vancouver
Temesgen TG, Teshome B, Njogu P. Treatment Outcomes and Associated Factors among Hospitalized Stroke Patients at Shashemene Referral Hospital, Ethiopia. Stroke Research and Treatment. 2018;2018:1-5. doi:10.1155/2018/8079578
BibTeX
@article{Temesgen2018,
author = {Temesgen, Tegegne Gobezie and Teshome, Berhanu and Njogu, Peter},
title = {Treatment Outcomes and Associated Factors among Hospitalized Stroke Patients at Shashemene Referral Hospital, Ethiopia},
journal = {Stroke Research and Treatment},
year = {2018},
volume = {2018},
pages = {1--5},
doi = {10.1155/2018/8079578}
}
EUVIMED